LeMaitre George W 4

What Happened
George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, reported open-market sales of 46,481 shares total: 18,600 shares sold on 2026-05-07 for $107.64 (total ~$2.00M) and 27,881 shares sold on 2026-05-08 for $108.69 (total ~$3.03M). Both transactions are coded as sales (S) and together amount to roughly $5.03 million. Sales are routine insider dispositions and do not by themselves indicate management’s view of the company.

Key Details

• Transaction dates and amounts:
  • 2026-05-07: 18,600 shares sold at a weighted average price reported $107.64; executed in multiple trades (range $107.10–$108.00). (See footnote F1.)
  • 2026-05-08: 27,881 shares sold at a weighted average price reported $108.69; executed in multiple trades (range $107.41–$109.73). (See footnote F2.)
• Aggregate proceeds: ~$5,032,413.
• Shares owned after transaction: Not disclosed in the excerpt provided in this summary (noted as unavailable).
• Footnote F3: Some shares are held in an irrevocable trust for the benefit of the reporting person’s children; the reporting person disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest.
• Filing timeliness: Form 4 was filed 2026-05-11 for trades on May 7–8, 2026. This filing date is within the normal Section 16 reporting window (filed timely).

Context

• These were open-market sales (code S). For retail investors, purchases are often more informative about insider conviction; sales can be routine (diversification, tax planning, trust transfers) and do not necessarily signal negative company prospects.
• Footnotes clarify pricing was a weighted average across multiple executions and some shares involve an irrevocable trust for the insider’s children.